• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术后非计划冠状动脉造影的发生率、预测因素及结果

Incidence, Predictors, and Outcomes of Unplanned Coronary Angiography After Transcatheter Aortic Valve Replacement.

作者信息

Phichaphop Asa, Okada Atsushi, Fukui Miho, Koike Hideki, Wang Cheng, Margonato Davide, Walser-Kuntz Evan, Stanberry Larissa I, Hamid Nadira, Cavalcante João L, Enriquez-Sarano Maurice, Lesser John R, Bapat Vinayak N, Sorajja Paul

机构信息

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Division of Cardiology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

出版信息

JACC Cardiovasc Interv. 2025 Jan 27;18(2):217-225. doi: 10.1016/j.jcin.2024.07.042. Epub 2024 Oct 23.

DOI:10.1016/j.jcin.2024.07.042
PMID:39453368
Abstract

BACKGROUND

Assessment of coronary artery disease (CAD) is critical in managing severe aortic stenosis. Unplanned coronary angiography after TAVR, with or without percutaneous coronary intervention, may present significant challenges.

OBJECTIVES

The aim of this study was to evaluate the incidence, predictors, and outcomes of unplanned coronary angiography after transcatheter aortic valve replacement (TAVR).

METHODS

All TAVR procedures between July 2015 and December 2021 were examined for the occurrence of unplanned angiography and for procedural success with percutaneous coronary intervention if attempted, and a machine learning prediction model was created.

RESULTS

Among 1,444 patients (median age 81 years, 59% men), 6.7% had unplanned post-TAVR angiography, 45% within the first year. The most common indication was acute coronary syndrome, which occurred in 3.3% overall. Patients with preprocedural CAD (50.1%) had a significantly higher incidence of unplanned angiography (10.5% vs 2.9%; P < 0.001) in comparison with others. In multivariable analysis, factors associated with unplanned angiography were age (>75 years; HR: 0.46; 95% CI: 0.30-0.71; P < 0.001), mean aortic valve gradient (HR: 0.82; 95% CI: 0.68-0.98; P = 0.031), dialysis (HR: 2.68; 95% CI: 1.07-6.74; P = 0.036), and CAD (HR: 2.96; 95% CI: 1.76-4.98; P < 0.001). In multivariate models, these same variables had areas under the curve of 0.71 to 0.77 for 5-year prediction of unplanned angiography.

CONCLUSIONS

Unplanned angiography post-TAVR occurs in about 1 in 15 patients, with about one-half occurring within the first year, about one-half due to acute coronary syndrome, and pre-existing CAD being the strongest predictor. For those considering TAVR and who have or are at risk for CAD, a comprehensive strategy to facilitate lifetime management is needed.

摘要

背景

评估冠状动脉疾病(CAD)对于严重主动脉瓣狭窄的管理至关重要。经导管主动脉瓣置换术(TAVR)后进行非计划冠状动脉造影,无论是否进行经皮冠状动脉介入治疗,都可能带来重大挑战。

目的

本研究旨在评估经导管主动脉瓣置换术(TAVR)后非计划冠状动脉造影的发生率、预测因素及结果。

方法

对2015年7月至2021年12月期间所有的TAVR手术进行检查,以确定非计划血管造影的发生情况以及如果尝试进行经皮冠状动脉介入治疗的手术成功率,并创建一个机器学习预测模型。

结果

在1444例患者(中位年龄81岁,59%为男性)中,6.7%在TAVR后进行了非计划血管造影,其中45%在第一年内进行。最常见的指征是急性冠状动脉综合征,总体发生率为3.3%。与其他患者相比,术前患有CAD(50.1%)的患者非计划血管造影的发生率显著更高(10.5%对2.9%;P<0.001)。在多变量分析中,与非计划血管造影相关的因素包括年龄(>75岁;HR:0.46;95%CI:0.30-0.71;P<0.001)、平均主动脉瓣梯度(HR:0.82;95%CI:0.68-0.98;P=0.031)、透析(HR:2.68;95%CI:1.07-6.74;P=0.036)和CAD(HR:2.96;95%CI:1.76-4.98;P<0.001)。在多变量模型中,这些相同变量对非计划血管造影5年预测的曲线下面积为0.71至0.77。

结论

TAVR后约每15例患者中有1例进行非计划血管造影,约一半发生在第一年内,约一半是由于急性冠状动脉综合征,而既往存在的CAD是最强的预测因素。对于那些考虑进行TAVR且患有CAD或有CAD风险的患者,需要一种全面的策略来促进终身管理。

相似文献

1
Incidence, Predictors, and Outcomes of Unplanned Coronary Angiography After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后非计划冠状动脉造影的发生率、预测因素及结果
JACC Cardiovasc Interv. 2025 Jan 27;18(2):217-225. doi: 10.1016/j.jcin.2024.07.042. Epub 2024 Oct 23.
2
Coronary angiography following transcatheter aortic valve replacement: Insights from the SWEDEHEART registry.经导管主动脉瓣置换术后的冠状动脉造影:来自 SWEDEHEART 注册研究的见解。
Catheter Cardiovasc Interv. 2024 Sep;104(3):570-582. doi: 10.1002/ccd.31171. Epub 2024 Jul 31.
3
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.冠心病及经皮冠状动脉介入治疗对接受经导管主动脉瓣置换术女性患者的影响:来自WIN-TAVI注册研究
Catheter Cardiovasc Interv. 2019 May 1;93(6):1124-1131. doi: 10.1002/ccd.28012. Epub 2018 Dec 4.
4
Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.未经治疗的慢性阻塞性冠状动脉疾病对经导管主动脉瓣置换术后结局的影响。
Eur Heart J. 2024 Jun 1;45(21):1890-1900. doi: 10.1093/eurheartj/ehae019.
5
Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement.SYNTAX 评分评估的冠状动脉疾病严重程度和经皮血运重建对经导管主动脉瓣置换术后结局的影响。
BMC Cardiovasc Disord. 2021 Nov 30;21(1):568. doi: 10.1186/s12872-021-02374-y.
6
Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis.冠状动脉疾病合并严重主动脉瓣狭窄患者的外科治疗与经导管治疗。
JACC Cardiovasc Interv. 2024 Nov 11;17(21):2472-2485. doi: 10.1016/j.jcin.2024.09.003.
7
Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement.自膨胀经导管主动脉瓣置换术后冠状动脉造影及介入治疗的发生率、技术安全性和可行性
Cardiovasc Revasc Med. 2019 May;20(5):371-375. doi: 10.1016/j.carrev.2019.01.026. Epub 2019 Feb 14.
8
Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.经导管主动脉瓣置换术- 主动脉瓣介入治疗中合并严重冠状动脉疾病患者的管理:杂交手术中经导管与外科手术方法的比较。
BMC Cardiovasc Disord. 2019 May 14;19(1):108. doi: 10.1186/s12872-019-1087-2.
9
Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.经导管主动脉瓣置换术治疗中的冠状动脉疾病、血运重建和临床结局:来自丹麦东部心脏注册中心的真实世界结果。
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):818-826. doi: 10.1002/ccd.27440. Epub 2017 Dec 7.
10
Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry.经导管主动脉瓣置换术后的冠状动脉事件:来自法国经导管主动脉瓣置换术注册研究的见解
JACC Cardiovasc Interv. 2025 Jan 27;18(2):229-243. doi: 10.1016/j.jcin.2024.09.005.

引用本文的文献

1
The TAVI Dilemma: Balloon-Expandable or Self-Expanding Transcatheter Heart Valve-Interpreting Current Evidence for Personalized Valve Selection.经导管主动脉瓣置入术的困境:球囊扩张式与自膨胀式经导管心脏瓣膜——解读个性化瓣膜选择的当前证据
J Clin Med. 2025 Aug 9;14(16):5651. doi: 10.3390/jcm14165651.
2
Analysis of potential categories of quality of life of transcatheter aortic valve replacement patients and discussion of their influencing factors.经导管主动脉瓣置换术患者生活质量潜在类别分析及其影响因素探讨。
BMC Cardiovasc Disord. 2025 Apr 5;25(1):259. doi: 10.1186/s12872-025-04718-4.
3
Lifetime Management in Aortic Valve Disease: Case-Based Tailored Strategies.
主动脉瓣疾病的终身管理:基于病例的个性化策略。
JACC Case Rep. 2025 Feb 19;30(4):103310. doi: 10.1016/j.jaccas.2025.103310. Epub 2025 Jan 25.